Martin Béliveau

1.2k total citations
29 papers, 942 citations indexed

About

Martin Béliveau is a scholar working on Oncology, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Martin Béliveau has authored 29 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Computational Theory and Mathematics and 4 papers in Infectious Diseases. Recurrent topics in Martin Béliveau's work include Computational Drug Discovery Methods (5 papers), HIV Research and Treatment (4 papers) and Analytical Chemistry and Chromatography (4 papers). Martin Béliveau is often cited by papers focused on Computational Drug Discovery Methods (5 papers), HIV Research and Treatment (4 papers) and Analytical Chemistry and Chromatography (4 papers). Martin Béliveau collaborates with scholars based in United States, Canada and Austria. Martin Béliveau's co-authors include Kannan Krishnan, Jean‐Francois Marier, Robert Tardif, Samer Mouksassi, Marc M. Baum, John A. Moss, Thomas J. Smith, Sunita Babbar, Geertrui F. Vanhove and Keith Bley and has published in prestigious journals such as Blood, The Science of The Total Environment and Neurology.

In The Last Decade

Martin Béliveau

28 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Béliveau United States 18 180 163 146 109 95 29 942
Kenneth R. Brouwer United States 24 277 1.5× 69 0.4× 245 1.7× 113 1.0× 199 2.1× 54 2.1k
Hongbing Wang United States 20 384 2.1× 79 0.5× 113 0.8× 44 0.4× 98 1.0× 55 1.4k
Kelly Bleasby United States 16 240 1.3× 35 0.2× 165 1.1× 45 0.4× 89 0.9× 21 1.1k
Greg Bondy Canada 12 223 1.2× 109 0.7× 136 0.9× 33 0.3× 47 0.5× 18 1.1k
Vikram Arya United States 18 177 1.0× 112 0.7× 134 0.9× 27 0.2× 92 1.0× 50 1.1k
Michael Török Switzerland 16 483 2.7× 84 0.5× 128 0.9× 45 0.4× 93 1.0× 24 1.3k
Cheryl L. Zimmerman United States 20 581 3.2× 335 2.1× 106 0.7× 46 0.4× 43 0.5× 63 1.4k
Phillip M. Gerk United States 20 331 1.8× 90 0.6× 77 0.5× 16 0.1× 103 1.1× 53 1.2k
Stephanie Faucette United States 14 322 1.8× 65 0.4× 192 1.3× 71 0.7× 77 0.8× 26 1.6k
Yasuna Kobayashi Japan 19 350 1.9× 39 0.2× 97 0.7× 21 0.2× 94 1.0× 51 1.4k

Countries citing papers authored by Martin Béliveau

Since Specialization
Citations

This map shows the geographic impact of Martin Béliveau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Béliveau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Béliveau more than expected).

Fields of papers citing papers by Martin Béliveau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Béliveau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Béliveau. The network helps show where Martin Béliveau may publish in the future.

Co-authorship network of co-authors of Martin Béliveau

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Béliveau. A scholar is included among the top collaborators of Martin Béliveau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Béliveau. Martin Béliveau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Béliveau, Martin, et al.. (2023). Animal‐to‐Human Dose Translation of ANTHRASIL for Treatment of Inhalational Anthrax in Healthy Adults, Obese Adults, and Pediatric Subjects. Clinical Pharmacology & Therapeutics. 115(2). 248–255. 1 indexed citations
2.
Ay, Cihan, Christian Schoergenhofer, Georg Gelbenegger, et al.. (2022). The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A. Blood. 141(10). 1147–1158. 18 indexed citations
3.
Gunawardana, Manjula, Simon G. Webster, Paul Webster, et al.. (2022). Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis. Scientific Reports. 12(1). 8224–8224. 11 indexed citations
4.
Gunawardana, Manjula, Rob Fanter, Simon G. Webster, et al.. (2022). Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis. Pharmaceutical Research. 40(7). 1657–1672. 3 indexed citations
5.
Baker, Brian, Barbara Schaeffler, Martin Béliveau, et al.. (2020). Population pharmacokinetic and exposure‐response analysis of eptinezumab in the treatment of episodic and chronic migraine. Pharmacology Research & Perspectives. 8(2). e00567–e00567. 48 indexed citations
6.
Bartko, Johann, Christian Schoergenhofer, Michael Schwameis, et al.. (2018). A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway. Clinical Pharmacology & Therapeutics. 104(4). 655–663. 44 indexed citations
7.
8.
Cornelio, Gerardo, María Tamayo, Michele Gargano, et al.. (2016). BTH1677 in combination with cetuximab with and without irinotecan in patients with advanced metastatic colorectal cancer. 5(3). 95–108. 4 indexed citations
9.
Gunawardana, Manjula, Rob Fanter, Flora Yang, et al.. (2015). Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis. Antimicrobial Agents and Chemotherapy. 59(7). 3913–3919. 133 indexed citations
10.
Lichter‐Konecki, Uta, George A. Díaz, J. Lawrence Merritt, et al.. (2011). Ammonia control in children with urea cycle disorders (UCDs); Phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate. Molecular Genetics and Metabolism. 103(4). 323–329. 53 indexed citations
11.
Lee, Brendan, William J. Rhead, George A. Díaz, et al.. (2010). Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: Safety, pharmacokinetics and ammonia control. Molecular Genetics and Metabolism. 100(3). 221–228. 72 indexed citations
12.
Marier, Jean‐Francois, et al.. (2009). Population Pharmacokinetics of Teduglutide Following Repeated Subcutanenous Administrations in Healthy Participants and in Patients With Short Bowel Syndrome and Crohn's Disease. The Journal of Clinical Pharmacology. 50(1). 36–49. 40 indexed citations
13.
Marier, Jean‐Francois, Martin Béliveau, Samer Mouksassi, et al.. (2008). Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon‐Like Peptide‐2 (GLP‐2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects. The Journal of Clinical Pharmacology. 48(11). 1289–1299. 65 indexed citations
14.
Béliveau, Martin & Kannan Krishnan. (2005). A Spreadsheet Program for Modeling Quantitative Structure-Pharmacokinetic Relationships for Inhaled Volatile Organics in Humans. SAR and QSAR in environmental research. 16(1-2). 63–77. 13 indexed citations
15.
Béliveau, Martin & Kannan Krishnan. (2005). Molecular Structure-Based Prediction of the Steady-State Blood Concentrations of Inhaled Organics in Rats. Toxicology Mechanisms and Methods. 15(5). 361–366. 1 indexed citations
16.
Béliveau, Martin, Robert Tardif, & Kannan Krishnan. (2003). Quantitative structure–property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. Toxicology and Applied Pharmacology. 189(3). 221–232. 36 indexed citations
17.
Krishnan, Kannan, Sami Haddad, Martin Béliveau, & Robert Tardif. (2002). Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures.. Environmental Health Perspectives. 110(suppl 6). 989–994. 40 indexed citations
18.
Béliveau, Martin, et al.. (2001). Quantitative structure–pharmacokinetic relationship modelling. The Science of The Total Environment. 274(1-3). 125–135. 37 indexed citations
19.
Béliveau, Martin, Ginette Charest‐Tardif, & Kannan Krishnan. (2001). Blood:air partition coefficients of individual and mixtures of trihalomethanes. Chemosphere. 44(3). 377–381. 8 indexed citations
20.
Béliveau, Martin & Kannan Krishnan. (2000). Estimation of rat blood:air partition coefficients of volatile organic chemicals using reconstituted mixtures of blood components. Toxicology Letters. 116(3). 183–188. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth R. Brouwer Breakdown of academic impact, for papers by Hongbing Wang Breakdown of academic impact, for papers by Kelly Bleasby Breakdown of academic impact, for papers by Greg Bondy Breakdown of academic impact, for papers by Vikram Arya Breakdown of academic impact, for papers by Michael Török Breakdown of academic impact, for papers by Cheryl L. Zimmerman Breakdown of academic impact, for papers by Phillip M. Gerk Breakdown of academic impact, for papers by Stephanie Faucette Breakdown of academic impact, for papers by Yasuna Kobayashi
Rankless by CCL
2026